FilingReader Intelligence

Pfizer India launches 20-valent pneumococcal vaccine for adults

August 11, 2025 at 02:09 PM UTCBy FilingReader AI

Pfizer Limited launched its 20-valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV20) for adults in India on August 11, 2025.

The single-shot vaccine provides protection against 20 serotypes of Streptococcus pneumoniae and is approved for adults aged 18 years and older. It offers wider serotype coverage than previous conjugate vaccines available in India.

According to managing director Meenakshi Nevatia, the launch addresses increasing demand for adult immunization in the country.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

BSE:PFIZERBombay Stock Exchange

News Alerts

Get instant email alerts when Pfizer publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →